Lipstatin (16; Figure 3 and Table 1) is a pancreatic lipase inhibitor produced by Streptomyces toxytricini that is used to combat obesity and diabetes by interfering with the gastrointestinal absorption of fat (Weibel et al., 1987). Here, PNLIP is linked to obesity disorder.